The Future of Small Molecules: Drugging the Undruggable.
Small molecules are now able to target previously ‘undruggable’ conditions, such as cancers and neurological disorders, I discuss how we got here a...
Small molecules are now able to target previously ‘undruggable’ conditions, such as cancers and neurological disorders, I discuss how we got here and what it means for the market. Click to read more.
In part two of this discussion, Dennis and I discuss the key barriers for entry for companies expanding into new territories and how to overcome these, whether you're a start-up or established company entering a new market. Click to listen.
In this final part, Dennis and I discuss new technologies to watch in the liquid biopsy market, as well as insights into innovation from behind the scenes at Predicine. Click to listen now.
Predicine With a background in research, pharma and commercial, Dennis gives insight into the true value of liquid biopsy. Click to listen.
This is the first in a new CM Life Science series discussing trends and insights into the diagnostics market. Here I'm joined by Delphine, to discuss European market expansion strategies within the diagnostics space. Click to listen.
Spencer talks to to Vered Caplan, CEO at Orgenesis Inc. about how their Point Of Care (POC) Platform aims to shape the Cell and Gene Therapies (CGT) ecosystem and market. Click here to listen.
Bioinformatics established its worth right from the start of the pandemic, solving complex real-life scientific problems with rapid effect. What does this leap forward mean for future life science discoveries? Click to read more.
As the Theranos and Holmes trial finally comes to a close, what has been the effect of the CEO’s 15 years of fraudulent tenure on the diagnostics industry?
African Swine Fever has been rife across key global swine markets for some years, but what does this mean for the wider market and its future? Click to read more.
These revolutionary companies are changing the game when it comes to neurological drug development, and thanks to recent funding they could be on the market sooner than you think. Click to find out more.
In this live recording, we were joined by a panel of leaders from the digital lab solutions space to discuss how data translates in the lab world, the challenges and strategies surrounding data maturity and the future of lab data. Click to listen.
In CM Life Science's latest webinar, we discussed how data translates into the lab world, the challenges surrounding data maturity and what lab data will look like in the future. Click to watch.
Cell and gene therapy continues to provide a better standard of living for millions of people with serious health conditions. Click to find out about some of the most exciting and innovative start-ups in this space.
More and more start-ups and MNEs are taking over, each of them contributing with innovative technologies and processes, promising a better future for the industry. Click to find out more.
What are organisations doing to improve diversity in clinical trials? Click to find out what a panel of CRO leaders had to say in our latest live webinar. Now available as a podcast.
While our industry has continued to raise awareness about the lack of diversity within clinical trials, actually addressing the issue remains our biggest challenge. Click to read how some leaders are addressing this.
In this episode of CM Conversations, our guest share his tips on hitting the ground running and building a team remotely, as well as the importance of investing in relationships. In his words, you should always be visible and available.
In pharma packaging and drug delivery, everyone is beginning to talk about sustainability again. How can we meet this increasing demand without causing further harm to our environment? Click to read about 5 companies embracing change.
Bioinformatics is transforming personalised care for cancer and rare diseases and aiding in novel drug discovery. In this article, I wanted to highlight the work and progress being made by some of the top companies in the space.
In the US, New Jersey is a life science powerhouse. It’s home to some of the most influential pharma manufacturers in the world. Click to find out some of the latest developments coming from this area.